RES administration in mice by Kaneko et al. prevents the development of CaCl2-induced abdominal aortic aneurysms and reduces the expression of inflammatory-related factors such as TNF-α, CD68, and ICAM1 [66]. This evidence concerns the gene ICAM1 and abdominal aortic aneurysm.